Receptor Expressed in Lymphoid Tissues (RELT) is a human Tumor Necrosis
Factor Receptor (TNFR) family member that has two identified homologous binding
partners, RELL1 and RELL2. This study sought to further understand the pattern
of RELT expression, the functional role of RELT family members, and the
mechanism of RELT-induced apoptosis. RELT protein expression was detected in the
spleen, lymph node, brain, breast and peripheral blood leukocytes (PBLs). A
smaller than expected size of RELT was observed in PBLs, suggesting a
proteolytically cleaved form of RELT. RELL1 and RELL2 overexpression activated
the p38 MAPK pathway more substantially than RELT in HEK-293 cells, and this
activation of p38 by RELT family members was blocked by dominant-negative mutant
forms of OSR1 or TRAF2, implicating these molecules in RELT family member
signaling. RELT was previously shown to induce apoptosis in human epithelial
cells despite lacking the characteristic death domain (DD) found in other TNFRs.
Seven deletion mutants of RELT that lacked differing portions of the
intracellular domain were created to assess whether RELT possesses a novel DD.
None of the deletion mutants induced apoptosis as efficiently as full-length
RELT, a result that is consistent with a novel DD being located at the
carboxyl-terminus. Interestingly, induction of apoptotic morphology by RELT
overexpression was not prevented when signaling by FADD or Caspase-8 was
blocked, indicating RELT induces apoptosis by a pathway distinct from other
death-inducing TNFRs such as TNFR1. Collectively, this study provides more
insights into RELT expression, RELT family member function, and the mechanism of
RELT-induced death.